NIAID Professional, Scientific and Technical Support Services

The National Institute of Allergy and Infectious Diseases (NIAID), operating under the Department of Health and Human Services National Institutes of Health, established this Master IDIQ to provide scientific and professional expertise supporting NIAID's current and emerging research priorities. The vehicle's last date to order was November 29, 2023, and ordering is now closed; the vehicle can no longer be pursued for new task orders.

The vehicle was awarded November 21, 2018, with a shared ceiling of $268 million. Since ordering closed nearly three years ago, BD evaluation should focus on whether this vehicle remains relevant for pipeline forecasting or retrospective win analysis rather than active pursuit. The vehicle's ordering window spanned approximately five years, from January 2019 through November 2023.

NIAID contracted specialized scientific expertise in basic, translational, and clinical research; vaccine development; laboratory research at biosafety levels 2, 3, and 4; veterinary and animal biosafety research at equivalent levels; and bioinformatics and computational biology. The vehicle issued 1,300 task orders with a combined potential value of $730.5 million. As of the most recent awards in February 2026, $542.4 million (74 percent) had been obligated, indicating the vehicle remained actively used post-ordering-deadline through obligation of existing orders.

Medical Science & Computing, LLC and Axle Informatics, LLC dominated the contract, holding $261.3 million and $213.8 million in combined potential value respectively. Gap Solutions, Inc., Kelly Services, Inc., and Camris International, LLC held the remaining $255.5 million combined. All 1,300 task orders were awarded unrestricted with no set-aside designations. Nearly all ordering activity flowed to NIAID itself—1,257 orders worth $688.1 million—with the Office of Logistics and Acquisition Operations placing 42 orders valued at $42.2 million. Task orders ranged from under $25,000 to approximately $5.1 million in potential value, typically priced on labor hours and labor plus fixed fee bases. Place of performance was NIAID facilities, primarily the Vaccine Research Center and Laboratory of Infectious Diseases.

The purpose of this IDIQ is to provide scientific and professional expertise to support the National Institute of Allergy and Infectious Diseases current and emerging research priorities. Support includes specialized scientific expertise related to basic, translational and clinical research; vaccine research and development; general laboratory research at BSL-2, -3 and -4; veterinary and scientific research in Animal Biosafety Level (ABSL) -2, -3and -4 environments; and bioinformatics and computational biology.